Federal Register / Vol. 86, No. 119 / Thursday, June 24, 2021 / Notices 33297 

or less in 12-point font, single-spaced. 

NIOSH will not respond to individual 

informational submissions nor publish 

publicly a compendium of responses. 

An informational submission in 

response to this Notice does not create 

any commitment on or behalf of CDC or 

HHS to develop or pursue any program 

or ideas discussed herein or related to 

PPE use for underserved user 

populations more generally. 

Disclaimer and Important Notes 

This Federal Register Notice is for 

planning purposes; it does not 

constitute a formal announcement for 

comprehensive applications. In 

accordance with Federal Acquisition 

Regulation 48 CFR 15.201(e), responses 

to this Notice are not offers and cannot 

be accepted by the Government to form 

a binding award. NIOSH will not 

provide reimbursement for costs 

incurred in responding to this Notice. 

John J. Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2021–13263 Filed 6–23–21; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–1266] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘HIV 

prevention among Latina transgender 

women who have sex with men: 

Evaluation of a locally developed 

intervention’’ to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on February 

25, 2021 to obtain comments from the 

public and affected agencies. CDC 

received one comment related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

HIV prevention among Latina 

transgender women who have sex with 

men: Evaluation of a locally developed 

intervention (OMB Control No. 0920– 

1266, Exp. 6/30/2021)—Revision— 

National Center for HIV/AIDS, Viral 

Hepatitis, STD and TB Prevention 

(NCHHSTP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The National Center for HIV/AIDS, 

Viral Hepatitis, STD and TB Prevention 

(NCHHSTP) is requesting approval for a 

two-year extension of a currently 

approved ICR (OMB Control No. 0920– 

1266), titled ‘‘HIV prevention among 

Latina transgender women who have 

sex with men: Evaluation of a locally 

developed intervention.’’ The goal of 

this study is to evaluate the efficacy of 

ChiCAS (Chicas Creando Acceso a la 

Salud [Chicas: Girls Creating Access to 

Health]), a locally developed and 

culturally congruent two-session 

Spanish-language small-group 

combination intervention, designed to 

promote consistent condom use, and 

access to, and participation in, preexposure prophylaxis (PrEP) and 

medically supervised hormone therapy 

by HIV seronegative Hispanic/Latina 

transgender women who have sex with 

men. 

The information collected through 

this study will be used to evaluate 

whether the ChiCAS intervention is an 

effective HIV-prevention strategy by 

assessing whether exposure to the 

intervention results in improvements in 

participants’ health and HIV prevention 

behaviors. The study will compare pre- 

(baseline) and post-intervention (sixmonth) levels of HIV risk among 

participants who have received the 

intervention and participants who have 

not yet received the intervention 

(delayed-intervention group). 

This study will be carried out in 

metropolitan areas in and around North 

Carolina, including Ashville, NC; 

Charlotte, NC; Research Triangle 

(metropolitan area of Greensboro, 

Winston-Salem and High Point NC); 

Raleigh, NC; Wilmington, NC; and 

Greenville, SC. The study population 

will include 140 HIV-negative Spanishspeaking transgender women. 

Participants will be adults, at least 18 

years of age, self-identify as male-tofemale transgender or report having 

been born male and identifying as 

female, and report having sex with at 

least one man in the past six months. 

We anticipate participants will be 

comprised mainly of racial/ethnic 

minority participants under 35 years of 

age, consistent with the epidemiology of 

HIV infection among transgender 

women. 

Intervention participants will be 

recruited to the study through a 

combination of approaches, including 

traditional print advertisement, referral, 

in-person outreach, and through word of 

mouth. A quantitative assessment will 

be used to collect information for this 

study, which will be delivered at the 

time of study enrollment, and again at 

a six-month follow up. The assessment 

will be used to measure differences in 

sexual risk knowledge, perceptions and 

behaviors including condom use, PrEP 

use, and use of medically supervised 

hormone therapy. Intervention 

mediators, including healthcare 

provider trust and communication 

skills, self-reported health status and 

healthcare access, community 

attachment and social support will also 

be measured. All participants will 

complete an assessment at baseline and 


khammond on DSKJM1Z7X2PROD with NOTICES
33298 Federal Register / Vol. 86, No. 119 / Thursday, June 24, 2021 / Notices 

again at a six-month follow-up, after 

enrolling in the study. The intervention 

group will participate in ChiCAS after 

completing the baseline assessment and 

the delayed intervention group will 

participate in ChiCAS after completing 

the six-month follow up assessment. 

CDC will also examine intervention 

experiences through in-depth interviews 

with 30 intervention group participants. 

The interviews will capture 

participants’ general experiences with 

the ChiCAS intervention, as well as 

their experiences and perceptions 

specific to the main study outcomes: 

PrEP knowledge, awareness, interest 

and use; condom skills and use; and 

hormone therapy knowledge, 

awareness, interest and use. 

It is expected that 50% of transgender 

women screened will meet study 

eligibility. We expect the initial 

screening and contact information 

gathering to take approximately four 

minutes to complete. The baseline 

assessment will take 60 minutes to 

complete and will be administered to 

140 participants. The follow up 

assessment will take 45 minutes to 

complete and will be administered to 

140 participants one time. The 

interview will take 90 minutes to 

complete and will be administered to 30 

participants from the intervention group 

one time. 

There are no costs to the respondents 

other than their time. The total 

estimated annualized burden hours are 

155. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

General Public—Adults ................................... Eligibility Screener .......................................... 140 1 3/60 

General Public—Adults ................................... Contact Information ........................................ 70 1 1/60 

General Public—Adults ................................... Baseline Assessment ..................................... 70 1 60/60 

General Public—Adults ................................... Follow-up Assessment ................................... 70 1 45/60 

General Public—Adults ................................... Interview ......................................................... 15 1 90/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–13436 Filed 6–23–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–0604; Docket No. CDC–2021– 

0057] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled ‘‘School-Associated Violent 

Deaths Surveillance System (SAVD).’’ 

DATES: CDC must receive written 

comments on or before August 23, 2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0057 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffery M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffery M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

School Associated Violent Death 

Surveillance System (OMB No. 0920– 

0604, expiration 07/31/2022)— 

Revision—National Center for Injury 

Prevention and Control (NCIPC), 


khammond on DSKJM1Z7X2PROD with NOTICES